A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers Karthik VenkatakrishnanWilliam G. KramerCristina Oliva Clinical Trial 30 March 2012 Pages: 1347 - 1355
Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy Merja KokkiPyry VälitaloHannu Kokki Clinical Trial 27 March 2012 Pages: 1357 - 1363
Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD) Maher R. KhdourAhmed F. HawwaJames C. McElnay Clinical Trial 05 April 2012 Pages: 1365 - 1373
Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma Barbro DahlénFederico P GómezRobert Rodriguez-Roisin Pharmacodynamics 29 March 2012 Pages: 1375 - 1383
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension William B. SmithThomas C. MarburyDiane R. Mould Pharmacodynamics Open access 29 March 2012 Pages: 1385 - 1394
Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients Xiao-Man ChuLi-Fang ZhangHai-Ping Hao Pharmacogenetics 05 April 2012 Pages: 1395 - 1401
Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery Xavier DelavennePaul Zuffereyfor The PROPICE Study Group Pharmacokinetics and Disposition 25 March 2012 Pages: 1403 - 1410
Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients Takafumi NaitoMasaki TashiroJunichi Kawakami Pharmacokinetics and Disposition 23 March 2012 Pages: 1411 - 1418
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus Robert SauermannThomas FeursteinMarkus Zeitlinger Pharmacokinetics and Disposition 23 March 2012 Pages: 1419 - 1423
Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database Marie C. BradleyTom FaheyCarmel M. Hughes Pharmacoepidemiology and Prescription 25 March 2012 Pages: 1425 - 1433
Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users Randi SelmerHege Salvesen BlixÅsmund Reikvam Pharmacoepidemiology and Prescription 18 March 2012 Pages: 1435 - 1442
The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective Anton PottegårdBine Kjøller BjerregaardSøren Ilsøe Moreno Pharmacoepidemiology and Prescription 21 March 2012 Pages: 1443 - 1450
Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data Jutta Kuepper-NybelenMartin HellmichIngrid Schubert Pharmacoepidemiology and Prescription 04 April 2012 Pages: 1451 - 1460
Spontaneous ejaculation with the use of noradrenergic reuptake inhibitors Ingrid OosterhuisLéon HeijtingEugène van Puijenbroek Letter to the Editors 23 March 2012 Pages: 1461 - 1462
Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population Rasmus Steen PedersenMette Marie Hougaard ChristensenKim Brøsen Letter to the Editors 04 April 2012 Pages: 1463 - 1464
